[{"id":"522ce461-bd5b-48fe-83ce-bfdef14e9b4b","acronym":"GEN001-201","url":"https://clinicaltrials.gov/study/NCT05419362","created_at":"2022-06-15T16:54:51.189Z","updated_at":"2025-02-25T16:17:49.248Z","phase":"Phase 2","brief_title":"GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer","source_id_and_acronym":"NCT05419362 - GEN001-201","lead_sponsor":"Genome \u0026 Company","biomarkers":" PD-L1","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Bavencio (avelumab) • GEN-001"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 42","initiation":"Initiation: 04/07/2022","start_date":" 04/07/2022","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-10-17"},{"id":"06cedc2c-5fd9-4935-a1db-659225305def","acronym":"","url":"https://clinicaltrials.gov/study/NCT05079503","created_at":"2021-10-15T14:53:04.668Z","updated_at":"2024-07-02T16:36:22.855Z","phase":"","brief_title":"Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer","source_id_and_acronym":"NCT05079503","lead_sponsor":"Korean Cancer Study Group","biomarkers":" CD8 • CD4","pipe":"","alterations":" ","tags":["CD8 • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GEN-001"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 40","initiation":"Initiation: 12/15/2021","start_date":" 12/15/2021","primary_txt":" Primary completion: 08/30/2023","primary_completion_date":" 08/30/2023","study_txt":" Completion: 01/30/2024","study_completion_date":" 01/30/2024","last_update_posted":"2021-10-15"}]